JP2006519815A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519815A5
JP2006519815A5 JP2006504814A JP2006504814A JP2006519815A5 JP 2006519815 A5 JP2006519815 A5 JP 2006519815A5 JP 2006504814 A JP2006504814 A JP 2006504814A JP 2006504814 A JP2006504814 A JP 2006504814A JP 2006519815 A5 JP2006519815 A5 JP 2006519815A5
Authority
JP
Japan
Prior art keywords
compound
reaction
carried out
alkyl group
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006504814A
Other languages
English (en)
Other versions
JP4805809B2 (ja
JP2006519815A (ja
Filing date
Publication date
Priority claimed from EP03290568A external-priority patent/EP1454900A1/en
Application filed filed Critical
Publication of JP2006519815A publication Critical patent/JP2006519815A/ja
Publication of JP2006519815A5 publication Critical patent/JP2006519815A5/ja
Application granted granted Critical
Publication of JP4805809B2 publication Critical patent/JP4805809B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (10)

  1. 式(II)
    Figure 2006519815
    (式中、R1は、環が任意にC36シクロアルキル基、C14アルキル基、C14アルコキシ基、ベンジル基又はハロゲン原子により置換されていてもよい、ピリジン環又はピリミジン環を表し;R2は水素原子、C16アルキル基又はハロゲン原子を表し;R3はC16アルキル基を表す)の化合物をフッ素ガスと反応させることによる、式(I):
    Figure 2006519815
    (式中、R1、R2及びR3は上記定義と同じ意味を有する)のピリジニル及びピリミジニル モノフッ素化βケトエステルの製造方法。
  2. 反応が、ギ酸、トリフルオロ酢酸、硫酸、トリフルオロメタンスルホン酸及びフッ化水素酸から選択される1又はそれ以上の酸の存在下で実施される請求項1に記載の方法。
  3. 反応が溶媒の不在下で実施される請求項1又は2に記載の方法。
  4. 反応が不活性溶媒たるアセトニトリル又はクロロホルムの存在下で実施される請求項1又は2に記載の方法。
  5. 反応が、溶媒の不在下にてフッ化水素酸の存在下で実施される請求項2又は3に記載の方法。
  6. 反応が、化合物(I)(式中、R1は、環が任意にC12アルキル基により置換されていてもよい、3若しくは4−ピリジニル又は4−若しくは5−ピリミジニルを表し、R2は水素原子又はC13アルキル基を表し、R3はC13アルキル基を表す)のために実施される請求項1〜5のいずれか1項に記載の方法。
  7. 反応が化合物(I):エチル2−フルオロ−3−オキソ−3−ピリジン−4−イルプロパノエート又はエチル2−フルオロ−3−オキソ−3−ピリミジン−4−イルプロパノエートのために実施される請求項1〜6のいずれか1項に記載の方法。
  8. 請求項1に規定の式(I)の化合物(ただし、化合物(I)はエチル2−フルオロ−3−オキソ−3−ピリジン−4−イルプロパノエートではない)。
  9. エチル2−フルオロ−3−オキソ−3−ピリミジン−4−イルプロパノエートからなる請求項1に規定の式(I)の化合物。
  10. R1が、環が任意に置換されていてもよいピリミジン環を表す請求項1に規定の式(I)の化合物。
JP2006504814A 2003-03-07 2004-03-05 ピリジニル及びピリミジニルモノフッ素化βケトエステルの製造方法 Expired - Fee Related JP4805809B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03290568A EP1454900A1 (en) 2003-03-07 2003-03-07 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
EP03290568.9 2003-03-07
PCT/EP2004/003052 WO2004078725A1 (en) 2003-03-07 2004-03-05 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters

Publications (3)

Publication Number Publication Date
JP2006519815A JP2006519815A (ja) 2006-08-31
JP2006519815A5 true JP2006519815A5 (ja) 2007-03-29
JP4805809B2 JP4805809B2 (ja) 2011-11-02

Family

ID=32799102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006504814A Expired - Fee Related JP4805809B2 (ja) 2003-03-07 2004-03-05 ピリジニル及びピリミジニルモノフッ素化βケトエステルの製造方法

Country Status (9)

Country Link
US (1) US7135569B2 (ja)
EP (2) EP1454900A1 (ja)
JP (1) JP4805809B2 (ja)
CN (1) CN100398518C (ja)
AT (1) ATE353877T1 (ja)
DE (1) DE602004004767T2 (ja)
ES (1) ES2281786T3 (ja)
RU (1) RU2330844C2 (ja)
WO (1) WO2004078725A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0996606B1 (en) * 1997-07-18 2002-01-16 F2 Chemicals Ltd. Catalysed fluorination of carbonyl compounds
US6455728B1 (en) * 1999-11-01 2002-09-24 Air Products And Chemicals, Inc. Direct fluorination process for preparing high purity 2-fluoro-1,3-dicarbonyl compounds using oxygen as a radical scavenger
EP1295885A1 (en) * 2001-09-21 2003-03-26 Sanofi-Synthelabo Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
EP1295884A1 (en) * 2001-09-21 2003-03-26 Sanofi-Synthelabo 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
DK1674456T3 (da) * 2001-09-21 2008-10-27 Sanofi Aventis Nye 1,4-benzothiazepin-1,1-dioxid-derivater med forbedrede egenskaber, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse

Similar Documents

Publication Publication Date Title
US8754230B2 (en) 4-pyridinone compounds and their use for cancer
US10513506B2 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl and processes of preparation
US7541469B2 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
EP1947092B1 (en) Method for producing nucleic acid base having perfluoroalkyl group
US8273878B2 (en) Process for the preparation of pyrimidine compounds
JP2009523146A5 (ja)
US8106202B2 (en) Method for making 1-substituted 1H-imidazo [4,5-C] quinolin-4-amine compounds and intermediates therefor
US20180327359A1 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
JP2005533804A5 (ja)
US20190382369A1 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
US20220281861A1 (en) Process For Preparing Aminopyrimidine Derivatives
JP2006519815A5 (ja)
JP2006526587A5 (ja)
US20190284158A1 (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
JP2008247919A5 (ja)
EP3292112B1 (en) Process for the preparation of alogliptin
RU2005131007A (ru) Способ получения монофторированных сложных бета-кетоэфиров пиридинила и пиримидинила
US8063226B2 (en) Process for preparing 2-amino-4-(haloalkyl) pyridine derivatives by cyclizing suitable nitrile precursors with nitrogen compounds
JP6372560B2 (ja) ピラゾール化合物の製造方法
CN1105996A (zh) 咪唑并吡啶类衍生物的制备方法
JP2000248189A5 (ja)
CN108409672B (zh) 一种铜盐催化合成多取代嘧啶的方法
Ikemoto et al. A Practical Synthesis of the Chronic Renal Disease Agent, 4, 5-Dihydro-3H-1, 4, 8b-triazaacenaphthylen-3-one Derivatives, Using Regioselective Chlorination of Ethyl 5-methylimidazo [1, 2-a] pyridine-3-carboxylate with N-Chlorosuccinimide
TWI705961B (zh) 亞托敏的製備方法
US20190276403A1 (en) T-butyl 2-carbamothioyl-2-(3-(5-(4-cyanophenoxy)pyridin-2-yl)-2-(2,4-difluorophenyl)-3,3-difluoro-2-hydroxypropyl)hydrazine-1-carboxylate and processes of preparation